Skip to main content
Skip to section navigation
Skip to footer
866.776.5907
Glassdoor
Linkedin
Twitter
YouTube
Header Utility
Client Services
Specimen Kits
Online Orders
Requisition Forms
About
Events
Molecular Tumor Board
Trade Shows
Webinars
Diagnostic Symposiums
Newsroom
Blog
Press Releases
Literature
Podcast
Videos
Our Team
Employee Benefits
Investors
NeoUniversity
Corporate Stewardship
Regulatory
Good Faith Estimate
Privacy
Terms of Use
Billing
Patients
Third Party Billing
Careers
Contact
NeoLINK Login
Main navigation
Diagnostic Services
Methodologies
Anatomic Pathology
Cytogenetics
FISH
Flow Cytometry
NGS
Sponsored Testing Programs
FOLR1 Ovarian Cancer Testing Program
KRAS Single Gene Test Program
Tech-Only Program Services
Laboratory Collaboration
Specialty Testing
Neo Comprehensive - Heme Cancers
Neo Comprehensive - Solid Tumor
COMPASS®
CancerTYPE ID®
Hereditary Cancer
InVisionFirst®-Lung Liquid Biopsy
Liquid Biopsy
NeoTYPE®
Early-Stage NSCLC Panel
Pharma Services
Why Choose NEO
Expertise
CDx Services
Project Requirements and Compliance
Lab Services
Anatomic Pathology
Molecular
Multiplexed Immunofluorescence
Flow Cytometry
FISH & Cytogenetics
CAR-T Services
Informatics & Data Solutions
Patients
Billing
In-home Blood Draws
Testing Terminology
Testing Methods and Tumor Profiling
Sponsored Testing Programs for Patients
Frequently Asked Questions
InVisionFirst®-Lung (Liquid Biopsy)
Test Menu
Search
Mobile Nav
All SEC Filings
Investor Relations
SEC Filings
All SEC Filings
Investor Relations
Investor Relations
Overview
News & Events
Press Releases
IR Calendar
Presentations
Literature
Email Alerts
Company Info
Overview
Executive Team
Tear Sheet
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Info
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
ESG Report
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
144
3
3/A
4
4/A
424B3
424B5
424B7
424B8
5
8-A12B
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DEFR14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREM14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3ASR
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Date
Form
Description
XBRL
Pages
02/08/22
5
Form 5: Annual statement of changes in beneficial ownership of securities
2
02/08/22
5
Form 5: Annual statement of changes in beneficial ownership of securities
2
02/04/22
SC 13G
Form SC 13G: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
02/04/22
SC 13G
Form SC 13G: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
01/27/22
SC 13G/A
Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
38
Page
39
Page
40
Page
41
Page
42
…
Page
225
Next Page
arrow_forward
Accessibility statement
Email alerts
Company profile
RSS news feed
Search
Main navigation
Diagnostic Services
Methodologies
Anatomic Pathology
Cytogenetics
FISH
Flow Cytometry
NGS
Sponsored Testing Programs
FOLR1 Ovarian Cancer Testing Program
KRAS Single Gene Test Program
Tech-Only Program Services
Laboratory Collaboration
Specialty Testing
Neo Comprehensive - Heme Cancers
Neo Comprehensive - Solid Tumor
COMPASS®
CancerTYPE ID®
Hereditary Cancer
InVisionFirst®-Lung Liquid Biopsy
Liquid Biopsy
NeoTYPE®
Early-Stage NSCLC Panel
Pharma Services
Why Choose NEO
Expertise
CDx Services
Project Requirements and Compliance
Lab Services
Anatomic Pathology
Molecular
Multiplexed Immunofluorescence
Flow Cytometry
FISH & Cytogenetics
CAR-T Services
Informatics & Data Solutions
Patients
Billing
In-home Blood Draws
Testing Terminology
Testing Methods and Tumor Profiling
Sponsored Testing Programs for Patients
Frequently Asked Questions
InVisionFirst®-Lung (Liquid Biopsy)
Test Menu
Search
Header Utility
Client Services
Specimen Kits
Online Orders
Requisition Forms
About
Events
Molecular Tumor Board
Trade Shows
Webinars
Diagnostic Symposiums
Newsroom
Blog
Press Releases
Literature
Podcast
Videos
Our Team
Employee Benefits
Investors
NeoUniversity
Corporate Stewardship
Regulatory
Good Faith Estimate
Privacy
Terms of Use
Billing
Patients
Third Party Billing
Careers
Contact
NeoLINK Login
Phone number
Glassdoor Icon
Linkedin Icon
Twitter Icon
YouTube Icon
Search